Basic fibroblast growth factor (bFGF or FGF-2) is an angiogenic and pl
eiotropic factor involved in the proliferation and differentiation of
numerous cell types. It is expressed mostly in tissues of mesoderm and
neuroectoderm origin, and plays an important role in the mesoderm ind
uction, together with transforming growth factor-beta (TGF-beta). Alth
ough hematopoietic cells derive from the mesoderm, relatively few stud
ies have addressed the role of bFGF in the hematopoietic system until
recently. It appears that bFGF is expressed and produced by bone marro
w stromal cells, as well as by cells from several mature peripheral bl
ood lineages. It is released and stored in the bone marrow extra-cellu
lar matrix. FGF-receptors (FGF-Rs) are expressed on nearly every cell
of hematopietic origin tested so far. Growing evidence shows that bFGF
can positively regulate hematopoiesis, by acting on various cellular
targets: stromal cells, early and committed hematopoietic progenitors,
and possibly some mature blood cells. It synergizes with hematopoieti
c cytokines, or antagonizes the negative regulatory effects of another
factor, TFG-beta, thus potentially playing a central role in hematopo
iesis.